Literature DB >> 30343349

Interaction between tissue factor pathway inhibitor-2 gene polymorphisms and environmental factors associated with coronary atherosclerosis in a Chinese Han.

Hairong Zhou1, Yanjuan Che2, Xiuhua Fu3, Hong Wei2, Xiuying Gao2, Yanxuan Chen1, Shaopeng Zhang1.   

Abstract

To investigate the association of single nucleotide polymorphisms (SNPs) within tissue factor pathway inhibitor-2 (TFPI-2) gene polymorphisms and additional gene-environment interaction with coronary atherosclerosis risk. Generalized multifactor dimensionality reduction (GMDR) was used to screen the best interaction combination among 4 SNPs, smoking and alcohol drinking. Logistic regression was performed to investigate association between 4 SNPs within TFPI-2 gene and coronary atherosclerosis risk. Coronary atherosclerosis risk was significantly higher in carriers with the A allele of rs34489123 within TFPI-2 gene than those with GG genotype (GA+AA versus GG), adjusted OR (95% CI) = 1.70 (1.20-2.31), and was also higher in carriers with the G allele of rs4264 within TFPI-2 gene than those with AA genotype (AG+GG versus AA), adjusted OR (95% CI) = 1.62 (1.21-2.11). GMDR model shown the best models for gene-environment interaction were rs34489123 and smoking after adjusting the covariates, which scored 10 out of 10 for cross-validation consistency and 0.0010 for the sign test. Heavy LD was found for SNPs rs34489123 and rs59805398 (D' value was more than 0.8). Compared to control individuals, the AG haplotypes appeared to be significantly associated with increased coronary atherosclerosis risk, OR (95% CI) = 1.73 (1.22-2.32). We found that the A allele of rs34489123 and the G allele of rs4264 within TFPI-2 gene, interaction between rs34489123 and smoking and AG haplotypes were all associated with increased coronary atherosclerosis risk.

Entities:  

Keywords:  Alcohol drinking; Coronary atherosclerosis; Interaction; Single nucleotide polymorphisms; Smoking; Tissue factor pathway inhibitor-2

Mesh:

Substances:

Year:  2019        PMID: 30343349     DOI: 10.1007/s11239-018-1755-6

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  23 in total

Review 1.  Inflammation, atherosclerosis, and coronary artery disease.

Authors:  Göran K Hansson
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

2.  Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.

Authors:  Zhenhua Xu; Debasish Maiti; Walter Kisiel; Elia J Duh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-10-05       Impact factor: 8.311

3.  Analysis of sequence variations in the promoter region of the human tissue factor pathway inhibitor 2 gene in apoplectic patients and blood donors.

Authors:  Sabine Siegling; Elmar Thyzel; Joerg Glahn; Knut Kleesiek; Christian Götting
Journal:  Ann Hematol       Date:  2005-10-25       Impact factor: 3.673

4.  Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis.

Authors:  Lacramioara Ivanciu; Robert D Gerard; Haiwang Tang; Florea Lupu; Cristina Lupu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11-30       Impact factor: 8.311

5.  Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention.

Authors:  R Cooper; J Cutler; P Desvigne-Nickens; S P Fortmann; L Friedman; R Havlik; G Hogelin; J Marler; P McGovern; G Morosco; L Mosca; T Pearson; J Stamler; D Stryer; T Thom
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

Review 6.  Role of endothelial dysfunction in atherosclerosis.

Authors:  Jean Davignon; Peter Ganz
Journal:  Circulation       Date:  2004-06-15       Impact factor: 29.690

7.  Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques.

Authors:  Christophe Zawadzki; Nicolas Chatelain; Marianne Delestre; Sophie Susen; Bruno Quesnel; Francis Juthier; Emmanuelle Jeanpierre; Richard Azzaoui; Delphine Corseaux; Joke Breyne; Gérard Torpier; Bart Staels; Eric Van Belle; Brigitte Jude
Journal:  Atherosclerosis       Date:  2008-10-19       Impact factor: 5.162

Review 8.  Inflammation and atherosclerosis.

Authors:  Göran K Hansson; Anna-Karin L Robertson; Cecilia Söderberg-Nauclér
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

9.  Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line.

Authors:  F Hubé; P Reverdiau; S Iochmann; C Cherpi-Antar; Y Gruel
Journal:  Thromb Res       Date:  2003-02-15       Impact factor: 3.944

10.  Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer.

Authors:  J Rollin; S Iochmann; C Bléchet; F Hubé; S Régina; S Guyétant; E Lemarié; P Reverdiau; Y Gruel
Journal:  Br J Cancer       Date:  2005-02-28       Impact factor: 7.640

View more
  2 in total

1.  Atherosclerosis Pathways are Activated in Pericoronary Adipose Tissue of Patients with Coronary Artery Disease.

Authors:  Michał Konwerski; Agnieszka Gromadka; Adam Arendarczyk; Marta Koblowska; Roksana Iwanicka-Nowicka; Radosław Wilimski; Paweł Czub; Krzysztof Jerzy Filipiak; Piotr Hendzel; Piotr Zielenkiewicz; Grzegorz Opolski; Aleksandra Gąsecka; Tomasz Mazurek
Journal:  J Inflamm Res       Date:  2021-10-20

2.  Gene-diet interactions and cardiovascular diseases: a systematic review of observational and clinical trials.

Authors:  Zayne M Roa-Díaz; Julian Teuscher; Magda Gamba; Marvin Bundo; Giorgia Grisotto; Faina Wehrli; Edna Gamboa; Lyda Z Rojas; Sergio A Gómez-Ochoa; Sanne Verhoog; Manuel Frias Vargas; Beatrice Minder; Oscar H Franco; Abbas Dehghan; Raha Pazoki; Pedro Marques-Vidal; Taulant Muka
Journal:  BMC Cardiovasc Disord       Date:  2022-08-20       Impact factor: 2.174

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.